155 related articles for article (PubMed ID: 37973156)
21. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.
Engelmann D; Koczan D; Ricken P; Rimpler U; Pahnke J; Li Z; Pützer BM
Endocr Relat Cancer; 2009 Mar; 16(1):211-24. PubMed ID: 18984779
[TBL] [Abstract][Full Text] [Related]
22. The Reality of Multiple Endocrine Neoplasia Type 2B Diagnosis: Awareness of Unique Physical Appearance Is Important.
Nagaoka R; Sugitani I; Sanada M; Jikuzono T; Okamura R; Igarashi T; Akasu H; Shimizu K
J Nippon Med Sch; 2018; 85(3):178-182. PubMed ID: 30135345
[TBL] [Abstract][Full Text] [Related]
23. [Hereditary neuroendrocrine tumors. Multiple endocrine neoplasia type 1 and 2].
Rinke A; Galan SR; Fendrich V; Kann PH; Bartsch DK; Gress TM
Internist (Berl); 2012 Apr; 53(4):400-7. PubMed ID: 22388921
[TBL] [Abstract][Full Text] [Related]
24. Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians.
Camacho CP; Hoff AO; Lindsey SC; Signorini PS; Valente FO; Oliveira MN; Kunii IS; Biscolla RP; Cerutti JM; Maciel RM
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1393-8. PubMed ID: 19169500
[TBL] [Abstract][Full Text] [Related]
25. Multiple endocrine neoplasia.
Thakker RV
Horm Res; 2001; 56 Suppl 1():67-72. PubMed ID: 11786689
[TBL] [Abstract][Full Text] [Related]
26. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene].
Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P
Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683
[TBL] [Abstract][Full Text] [Related]
27. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
28. Multiple endocrine neoplasia.
White ML; Doherty GM
Surg Oncol Clin N Am; 2008 Apr; 17(2):439-59, x. PubMed ID: 18375361
[TBL] [Abstract][Full Text] [Related]
29. Investigating familial endocrine neoplasia syndromes in children.
Johnston LB; Chew SL; Lowe D; Reznek R; Monson JP; Savage MO
Horm Res; 2001; 55 Suppl 1():31-5. PubMed ID: 11408759
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
Thakker RV
Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
[TBL] [Abstract][Full Text] [Related]
31. RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China.
Qi XP; Chen XL; Ma JM; Du ZF; Fei J; Yang CP; Cheng J; Song QZ; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Liu WT; Zhao Y; Chen CY; Jiang HL; Ke HP; Zhang XN
Thyroid; 2012 Dec; 22(12):1257-65. PubMed ID: 23210566
[TBL] [Abstract][Full Text] [Related]
32. Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
Salvatore D; Melillo RM; Monaco C; Visconti R; Fenzi G; Vecchio G; Fusco A; Santoro M
Cancer Res; 2001 Feb; 61(4):1426-31. PubMed ID: 11245446
[TBL] [Abstract][Full Text] [Related]
33. Multiple endocrine neoplasia syndrome: genetic basis for clinical management.
Carling T
Curr Opin Oncol; 2005 Jan; 17(1):7-12. PubMed ID: 15608505
[TBL] [Abstract][Full Text] [Related]
34. MEN 1 and 2: the role of diagnostic imaging.
Gollini P; Cataldi A; Fava C
Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699
[TBL] [Abstract][Full Text] [Related]
35. ["Graded early warning system" of
Qi XM; Li WX; Huang JW; Huang ZG; Chen XH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):212-217. PubMed ID: 36878499
[No Abstract] [Full Text] [Related]
36. RET activation by germline MEN2A and MEN2B mutations.
Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
[TBL] [Abstract][Full Text] [Related]
37. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
[TBL] [Abstract][Full Text] [Related]
38. Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B.
Zenaty D; Aigrain Y; Peuchmaur M; Philippe-Chomette P; Baumann C; Cornelis F; Hugot JP; Chevenne D; Barbu V; Guillausseau PJ; Schlumberger M; Carel JC; Travagli JP; Léger J
Eur J Endocrinol; 2009 May; 160(5):807-13. PubMed ID: 19240193
[TBL] [Abstract][Full Text] [Related]
39. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
Erdogan MF; Gursoy A
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
[TBL] [Abstract][Full Text] [Related]
40. Multiple endocrine neoplasia type 2: an overview.
Moline J; Eng C
Genet Med; 2011 Sep; 13(9):755-64. PubMed ID: 21552134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
